R A van Lier
Overview
Explore the profile of R A van Lier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
3545
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
ten Berge I, Gamadia L, Remmerswaal E, Surachno S, Weel J, Toebes M, et al.
Transplant Proc
. 2001 Dec;
33(7-8):3630.
PMID: 11750541
No abstract available.
2.
Arens R, Tesselaar K, Baars P, van Schijndel G, Hendriks J, Pals S, et al.
Immunity
. 2001 Dec;
15(5):801-12.
PMID: 11728341
The interaction between the TNF receptor family member CD27 and its ligand CD70 provides a costimulatory signal for T cell expansion. Normally, tightly regulated expression of CD70 ensures the transient...
3.
Killestein J, Kalkers N, Meilof J, Barkhof F, van Lier R, Polman C
Neurology
. 2001 Sep;
57(6):1129-31.
PMID: 11571353
Reliable laboratory prognostic factors for MS are still lacking. The predictive value of markers of T-cell activation for long-term disease progression was investigated. Flow cytometry measurements were correlated to changes...
4.
Rentenaar R, de Metz J, Bunders M, Gouma D, Romijn J, Sauerwein H, et al.
Clin Exp Immunol
. 2001 Sep;
125(3):401-8.
PMID: 11531947
Antigen-induced activation of T cells is determined by many factors. Among these factors are (i) the number of T-cell receptors (TCRs) triggered by TCR ligands on antigen-presenting cells (APCs), and...
5.
Killestein J, Rep M, Barkhof F, Roos M, Ader H, van Lier R, et al.
J Neuroimmunol
. 2001 Aug;
118(2):286-94.
PMID: 11498263
Background: The role of T cell subpopulations and their ability to produce immunoregulatory cytokines has been extensively studied in multiple sclerosis (MS). However, the exact mechanisms by which T cells...
6.
Killestein J, Den Drijver B, van der Graaff W, Uitdehaag B, Polman C, van Lier R
Mult Scler
. 2001 Jul;
7(3):145-50.
PMID: 11475436
Objective: To evaluate the expression of cytokines in both CD4+ and CD8+ T cells derived from peripheral blood of untreated multiple sclerosis (MS) patients with either relapsing-remitting (RR), secondary progressive...
7.
Gamadia L, Rentenaar R, Baars P, Remmerswaal E, Surachno S, Weel J, et al.
Blood
. 2001 Jul;
98(3):754-61.
PMID: 11468176
During immunosuppression, cytomegalovirus (CMV) can reactivate and cause serious clinical problems. Normally, abundant virus replication is suppressed by immune effector mechanisms. To study the interaction between CD8(+) T cells and...
8.
Jaspars L, Vos W, Aust G, van Lier R, Hamann J
Tissue Antigens
. 2001 Jul;
57(4):325-31.
PMID: 11380941
CD97 is a founding member of the EGF-TM7 family of class II seven-span transmembrane (7-TM) receptors. CD97 has an extended extracellular region with several N-terminal epidermal growth factor (EGF)-like domains,...
9.
Rentenaar R, Gamadia L, van der Hoek N, van Diepen F, BOOM R, Weel J, et al.
Transplant Proc
. 2001 May;
33(3):2313-4.
PMID: 11377542
No abstract available.
10.
Meijer R, Yong S, ten Berge I, van Lier R, Schellekens P
Clin Exp Immunol
. 2001 Apr;
123(3):511-9.
PMID: 11298141
CLB T3/4.A is a non FcR-binding CD3 mAb of the murine IgA isotype, which may be used as an alternative for the mitogenic OKT3 mAb in the treatment of acute...